I HAVE EGPA
AND A WAY FORWARD
Actual patient compensated by GSK for her time.
NUCALA is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).

NUCALA—the first and only FDA-approved treatment for eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome)"toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"1

Chat